Skip to main content

Table 1 Description of subjects with/without psoriasis studied

From: Metabolic syndrome and its components in patients with psoriasis

Characteristics Subjects with psoriasis Subjects free from psoriasis p-values
Mean ± SD Mean ± SD
Median (minimal-maximal values) Median (minimal-maximal values)
Sex (♂/♀) 55/47 55/47 ns
Age (years) 49.32 ± 13.47 48.71 ± 13.84 ns
BMI (kg/m2) 27.7 (18.9-41.79) 27.36 (18.24-40.5) ns
History    
 - DM 14/102 (13.72%) 4/102 (3.92%) 0.024
 - HT 27/102 (26.47%) 21/102 (20.58%) ns
 - DLP 36/102 (35.29%) 28/102 (27.45%) ns
 - CD 6/102 (5.9%) 4/102 (3.92%) ns
Blood pressure(mmHg)    
 - Systolic 130.75 (96-200) 124.5 (90-184) 0.006
 - Diastolic 80.67 ± 12.38 78.06 ± 10.72 ns
Waist circumference (cm)    ns
99 (75-122) 98 (67-130)  
87 (63-120) 83 (63-116)
Active tobacco consumption 35/102 (34.31%) 23/102 (22.54%) 0.063
Dietary control 24/102 (23.52%) 15/102 (14.7%) ns
Exercise    
 - Low 16/102 (15.6%) 17/102 (16.6%) ns
 - Moderate 47/102 (46%) 59/102 (55.8%)
 - High 35/102 (34.3%) 23/102 (22.5%)
Consumption of alcohol (≥3/day) 55/102 (53.9%) 67/102 (65.6%) ns
Fasting glycaemia (mg/dL) 99.1 (68.5-232.5) 91.95 (68.5-151) ns
Glycaemia 120 min (mg/dL) 93.7 (45.1-264.9) 95.5 (48.7-286) ns
HOMA Index 2.66 (0.85-22.73) 2.28 (0.51-9.42) <0.001
Total Cholesterol (mg/dL) 201.16 (116.5-286) 197.17 (127-301.5) ns
HDL cholesterol (mg/dL) 50.04 ± 11.91 51.66 ± 13.74) ns
LDL cholesterol (mg/dL) 124.56 ± 28.77 128.02 ± 29.34 ns
Triglycerides (mg/dL) 98.19 (27.13-787.5) 87 (28.9-540) ns
  1. BMI: Body Mass Index. DM: Diabetes Mellitus. DLP: Dyslipidaemia. HT: Arterial Hypertension. CD: Coronary disease.